The clinical application of conventional photodynamic therapy (PDT) is often limited by the nonspecific phototoxicity of "always-on" photosensitizers. Activatable photosensitizers (aPS) have emerged as a promising solution to this challenge....
Wang et al. (2026) studied this question.